source
- Luma Group closes $410 million, 15-year life-science venture fundLuma Group announced that its first life‑science venture capital fund has reached final close, raising $410 million for a 15‑year investment period. The New York‑based firm said the capital will be…
- Encoded Therapeutics secures $275M Series F to push Dravet gene therapy and expand manufacturingEncoded Therapeutics, a biotech focused on neuro‑genetic disorders, announced a $275 million Series F financing round. The capital was co‑led by Google Ventures and an undisclosed healthcare fund,…